-
2
-
-
0032981042
-
Novel therapies for inflammatory bowel disease
-
Sands BE: Novel therapies for inflammatory bowel disease. Gastroenterol Clin North Am 18:323-351, 1999
-
(1999)
Gastroenterol Clin North Am
, vol.18
, pp. 323-351
-
-
Sands, B.E.1
-
3
-
-
0002218823
-
Crohn's disease
-
M Feldman, LS Friedman, MH Sleisenger (eds). New York, Saunders
-
Sands BE: Crohn's disease. In Gastrointestinal and Liver Disease. M Feldman, LS Friedman, MH Sleisenger (eds). New York, Saunders, 2002, pp 2005-2038
-
(2002)
Gastrointestinal and Liver Disease
, pp. 2005-2038
-
-
Sands, B.E.1
-
4
-
-
0027959253
-
Oxidants and free radicals in inflammatory bowel disease
-
Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet B44:859-861, 1994
-
(1994)
Lancet
, vol.B44
, pp. 859-861
-
-
Grisham, M.B.1
-
5
-
-
0035158627
-
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide
-
Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross CR, Granger DN: Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: Divergent roles of superoxide and nitric oxide. J Exp Med 194:1207-1218, 2001
-
(2001)
J Exp Med
, vol.194
, pp. 1207-1218
-
-
Krieglstein, C.F.1
Cerwinka, W.H.2
Laroux, F.S.3
Salter, J.W.4
Russell, J.M.5
Schuermann, G.6
Grisham, M.B.7
Ross, C.R.8
Granger, D.N.9
-
6
-
-
0029115715
-
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity
-
Rachmilewitz D, Karmeli F, Okon E, Bursztyn M: Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37:247-255, 1995
-
(1995)
Gut
, vol.37
, pp. 247-255
-
-
Rachmilewitz, D.1
Karmeli, F.2
Okon, E.3
Bursztyn, M.4
-
7
-
-
0034127618
-
Role of inducible nitric oxide synthase in dextran sulfate sodium-induced colitis
-
Yoshida Y, Iwai A, Itoh K, Tanaka M, Kato S, Hokari R, Miyahara T, Koyama H, Miura S, Kobayashi M: Role of inducible nitric oxide synthase in dextran sulfate sodium-induced colitis. Aliment Pharmacol Ther 14:26-32, 2000
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 26-32
-
-
Yoshida, Y.1
Iwai, A.2
Itoh, K.3
Tanaka, M.4
Kato, S.5
Hokari, R.6
Miyahara, T.7
Koyama, H.8
Miura, S.9
Kobayashi, M.10
-
8
-
-
0032712861
-
Role of inducible nitric oxide synthase in Trinitrobenzene sulphonic acid induced colitis in mice
-
McCafferty DM, Miampamba M, Shiota E: Role of inducible nitric oxide synthase in Trinitrobenzene sulphonic acid induced colitis in mice. Gut 45:199-209, 1999
-
(1999)
Gut
, vol.45
, pp. 199-209
-
-
McCafferty, D.M.1
Miampamba, M.2
Shiota, E.3
-
9
-
-
0034074793
-
Replenishment of glutathione levels improves mucosal function in experimental acute colitis
-
Ardite E, Sans M, Panés J, Romero FJ, Pique JM, Fernandez-Checa JC: Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest 80:735-744, 2000
-
(2000)
Lab Invest
, vol.80
, pp. 735-744
-
-
Ardite, E.1
Sans, M.2
Panés, J.3
Romero, F.J.4
Pique, J.M.5
Fernandez-Checa, J.C.6
-
10
-
-
0036193633
-
α Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice
-
Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T, Kotake Y: α Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice. Antioxidants Redox Signal 4:195-206, 2002
-
(2002)
Antioxidants Redox Signal
, vol.4
, pp. 195-206
-
-
Naito, Y.1
Takagi, T.2
Ishikawa, T.3
Handa, O.4
Matsumoto, N.5
Yagi, N.6
Matsuyama, K.7
Yoshida, N.8
Yoshikawa, T.9
Kotake, Y.10
-
11
-
-
0024552818
-
Hapten-induced model of chronic inflammation and ulceration in the rat colon
-
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL: Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803, 1989
-
(1989)
Gastroenterology
, vol.96
, pp. 795-803
-
-
Morris, G.P.1
Beck, P.L.2
Herridge, M.S.3
Depew, W.T.4
Szewczuk, M.R.5
Wallace, J.L.6
-
12
-
-
0023934636
-
Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis
-
Wallace JI: Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol Pharmacol 66:422-425, 1988
-
(1988)
Can J Physiol Pharmacol
, vol.66
, pp. 422-425
-
-
Wallace, J.I.1
-
13
-
-
0344466539
-
The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through down regulation of cytokine production
-
Galvez J, Garrido M, Rodriguez-Cabezas ME, Ramis I, de Medina FS, Merlos M, Zarzuelo A: The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through down regulation of cytokine production. Inflamm Bowel Dis 9:363-371, 2003
-
(2003)
Inflamm Bowel Dis
, vol.9
, pp. 363-371
-
-
Galvez, J.1
Garrido, M.2
Rodriguez-Cabezas, M.E.3
Ramis, I.4
De Medina, F.S.5
Merlos, M.6
Zarzuelo, A.7
-
14
-
-
1542708751
-
Glutathione supplementation improves oxidative damage in experimental colitis
-
Loguercio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, Del Vecchio Blanco C: Glutathione supplementation improves oxidative damage in experimental colitis. Dig Liver Dis 35:635-641, 2003
-
(2003)
Dig Liver Dis
, vol.35
, pp. 635-641
-
-
Loguercio, C.1
D'Argenio, G.2
Delle Cave, M.3
Cosenza, V.4
Della Valle, N.5
Mazzacca, G.6
Del Vecchio Blanco, C.7
-
15
-
-
0034177606
-
A radical approach to treating inflammation
-
Grisham MB: A radical approach to treating inflammation. Trends Pharmacol Sci 21:119-120, 2000
-
(2000)
Trends Pharmacol Sci
, vol.21
, pp. 119-120
-
-
Grisham, M.B.1
-
16
-
-
0033637218
-
Mesalamine inhibits activation of transcription factor NF-kB in inflamed mucosa of patients with ulcerative colitis
-
Bantel H, Berg C, Vieth M, Stolte M, Kruis W, Schulze-Osthoff K: Mesalamine inhibits activation of transcription factor NF-kB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol 95:3452-3457, 2000
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 3452-3457
-
-
Bantel, H.1
Berg, C.2
Vieth, M.3
Stolte, M.4
Kruis, W.5
Schulze-Osthoff, K.6
-
17
-
-
0033636562
-
Progress in understanding the mechanism of action of 5-aminosalicylic acid
-
MacDermott RP: Progress in understanding the mechanism of action of 5-aminosalicylic acid. Am J Gastroenterol 95:3343-3345, 2000
-
(2000)
Am J Gastroenterol
, vol.95
, pp. 3343-3345
-
-
MacDermott, R.P.1
-
18
-
-
0025907050
-
Effect of sulfasalazine on B cell
-
Imai F, Suzuki T, Ishibashi T, Dohi Y: Effect of sulfasalazine on B cell. Clin Exp Rheumatol 9:256-264, 1991
-
(1991)
Clin Exp Rheumatol
, vol.9
, pp. 256-264
-
-
Imai, F.1
Suzuki, T.2
Ishibashi, T.3
Dohi, Y.4
-
19
-
-
0029872644
-
Effects of antirheumatic agents on cytokines
-
Barrera P, Boerbooms AM, Van De Putte LB, van der Meer JW: Effects of antirheumatic agents on cytokines. Semin Arthritis Rheum 25:234-253, 1996
-
(1996)
Semin Arthritis Rheum
, vol.25
, pp. 234-253
-
-
Barrera, P.1
Boerbooms, A.M.2
Van De Putte, L.B.3
Van Der Meer, J.W.4
-
20
-
-
0027414728
-
Inhibition of leukocyte adhesion molecule upregulation by tumor necrosis factor α: A novel mechanism of action of sulfasalazine
-
Green field SM, Hambhin AS, Shakoor ZS, Teare JP, Punchard NA, Thompson RP: Inhibition of leukocyte adhesion molecule upregulation by tumor necrosis factor α: a novel mechanism of action of sulfasalazine. Gut 34:252-256, 1993
-
(1993)
Gut
, vol.34
, pp. 252-256
-
-
Greenfield, S.M.1
Hambhin, A.S.2
Shakoor, Z.S.3
Teare, J.P.4
Punchard, N.A.5
Thompson, R.P.6
-
21
-
-
0025321145
-
Role of reactive oxygen metabolites in experimental colitis
-
Keshavarzian, A, Morgan G, Sedghi S, Gordon JH, Doria M: Role of reactive oxygen metabolites in experimental colitis. Gut 31:786-790, 1990
-
(1990)
Gut
, vol.31
, pp. 786-790
-
-
Keshavarzian, A.1
Morgan, G.2
Sedghi, S.3
Gordon, J.H.4
Doria, M.5
-
22
-
-
0024212465
-
SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis
-
Miller MJ, McNeill H, Mullane KM, Caravella SJ, Clark DA: SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. Am J Physiol 255:G556-G565, 1988
-
(1988)
Am J Physiol
, vol.255
-
-
Miller, M.J.1
McNeill, H.2
Mullane, K.M.3
Caravella, S.J.4
Clark, D.A.5
-
23
-
-
0023901382
-
Contribution of oxygen-derived free radicals to experimental necrotizing enterocolitis
-
Clark DA, Fornabaio DM, McNeill H, Mullane KM, Carvella SJ, Miller MJ: Contribution of oxygen-derived free radicals to experimental necrotizing enterocolitis. Am J Physiol 130:537-542, 1988
-
(1988)
Am J Physiol
, vol.130
, pp. 537-542
-
-
Clark, D.A.1
Fornabaio, D.M.2
McNeill, H.3
Mullane, K.M.4
Carvella, S.J.5
Miller, M.J.6
-
24
-
-
0029115715
-
Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity
-
Rachmilewitz D, Karmeli F, Okon E, Bursztyn M: Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 37:247-255, 1995
-
(1995)
Gut
, vol.37
, pp. 247-255
-
-
Rachmilewitz, D.1
Karmeli, F.2
Okon, E.3
Bursztyn, M.4
-
25
-
-
0034127618
-
Role of inducible nitric oxide synthase in dextran sulfate sodium-induced colitis
-
Yoshida Y, Iwai A, Itoh K, Tanaka M, Kato S, Hokari R, Miyahara T, Koyama H, Miura S, and Kobayashi M: Role of inducible nitric oxide synthase in dextran sulfate sodium-induced colitis. Ailment Pharmacol Ther 14:26-32, 2000
-
(2000)
Ailment Pharmacol Ther
, vol.14
, pp. 26-32
-
-
Yoshida, Y.1
Iwai, A.2
Itoh, K.3
Tanaka, M.4
Kato, S.5
Hokari, R.6
Miyahara, T.7
Koyama, H.8
Miura, S.9
Kobayashi, M.10
-
26
-
-
0032712861
-
Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice
-
McCafferty DM, Miampamba M, Shiota E, Sharkey KA, Kubes P: Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45:864-873, 1999
-
(1999)
Gut
, vol.45
, pp. 864-873
-
-
McCafferty, D.M.1
Miampamba, M.2
Shiota, E.3
Sharkey, K.A.4
Kubes, P.5
-
27
-
-
0032855666
-
Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase
-
Zingarelli B, Szabo C, Salzman AL: Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 45:199-209, 1999
-
(1999)
Gut
, vol.45
, pp. 199-209
-
-
Zingarelli, B.1
Szabo, C.2
Salzman, A.L.3
-
28
-
-
0034253943
-
Nitric oxide and intestinal inflammation
-
Kubes P, McCafferty DM: Nitric oxide and intestinal inflammation. Am J Med 109:150-158, 2000
-
(2000)
Am J Med
, vol.109
, pp. 150-158
-
-
Kubes, P.1
McCafferty, D.M.2
|